학술논문
Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
Document Type
Article
Author
Aggarwal, Rahul ; Starzinski, Stephanie; de Kouchkovsky, Ivan; Koshkin, Vadim; Bose, Rohit; Chou, Jonathan; Desai, Arpita; Kwon, Daniel; Kaushal, Samuel; Trihy, Lauren; Rastogi, Medini; Ippisch, Robin; Aslam, Maya; Friedlander, Terence; Feng, Felix; Oh, David; Cheung, Alexander; Small, Eric; Evans, Michael; Fong, Lawrence ; Hope, Thomas A
Source
In The Lancet Oncology November 2023 24(11):1266-1276
Subject
Language
ISSN
1470-2045